• Evaluation of the prevalence of pathogens in colonic mucosa and peripheral blood of patients with inflammatory bowel disease (IBD), correlating their presence in the mucosa with patterns of disease activity, response to therapy, and systemic replicative activity, compared to a control group - Dra. Susana Lopes
  • Genetic variations in Antioxidant genes: implications in IBD – Dra. Cristiana Costa Pereira
  • Glycosylation of the T Cell Receptor: a new mechanism underlying Inflammatory Bowel Disease pathogenesis. Implications for therapy stratification – Dra. Salomé Pinho
  • Performance of Interferon Gamma Release Assays (IGRA) in the screening and monitoring tuberculosis in Patients with Inflammatory Bowel Diseases (IBD) under anti-TNF therapy – Dra. Cândida Abreu
  • The Influence of Immunosuppressive Therapies on Anti-Drug Antibodies Production In IBD Patients Treated With TNF – Dra. Sandra Garcês
  • Transmural Small Bowel Wall Changes at MR enterography during treatment with azathioprine or anti-TNF agents: characterization, prognostic impactand correlation with clinical, endoscopic and fecal Markers – Dr. Luís Guimarães
01 de março de 2023
21st ECCO Intensive Course for Trainees in IBD
De 19 de abril a 21 de abril de 2023
Reunião Anual GEDII
©2022 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis | Termos e condiçoes
Desenvolvido por DogmaSis